Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Atorvastatin

    Tag: Atorvastatin

    You Searched For "Atorvastatin"
    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details

    NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details

    Farhat Nasim20 Dec 2019 11:55 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    CDSCO declares 36 samples of Atorvastatin, Metformin, Paracetamol, others as Not of Standard Quality

    Farhat Nasim25 Nov 2019 3:41 PM IST
    New Delhi: The nodal drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 36 drugs as not of standard...
    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    NPPA fixes retail price of 12 combo drugs including Aspirin, Atorvastatin, Metformin; Details

    Farhat Nasim17 Nov 2019 1:08 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 4:29 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    CDSCO declares 21 drug samples Not of Standard Quality

    CDSCO declares 21 drug samples Not of Standard Quality

    Farhat Nasim29 Oct 2019 4:07 PM IST
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared batches of 21 drugs made by certain...
    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

    Medical Dialogues Bureau23 Aug 2019 12:27 PM IST
    New Delhi: In a move to regularise Fixed Dose Combinations (FDCs), the Central Drugs Standard Control Organization (CDSCO) has notified the process to...
    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    Farhat Nasim27 Jun 2019 4:07 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Prices of 21 New Drugs fixed by NPPA; Details

    Prices of 21 New Drugs fixed by NPPA; Details

    Meghna A Singhania4 April 2019 10:00 AM IST
    The NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla,...
    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

    Meghna A Singhania3 April 2019 6:08 PM IST
    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 847 formulations under the...
    Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol

    Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol

    Farhat Nasim8 March 2019 9:45 AM IST
    Atorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
    Morepen labs gets USFDA approval for 2 bulk drug manufacturing units

    Morepen labs gets USFDA approval for 2 bulk drug manufacturing units

    Ruby Khatun Khatun1 Aug 2018 10:47 AM IST
    New Delhi: Morepen Laboratories Ltd. has received USFDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok